These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3611272)

  • 41. The pharmacokinetics of proguanil in human subjects following a single oral dose.
    Chiluba EM; Fletcher KA; Price AH
    Afr J Med Med Sci; 1987 Mar; 16(1):43-6. PubMed ID: 3037875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-performance liquid chromatographic assay for the benzotriazine di-N-oxide (SR 4233) and its reduced metabolites in biological materials.
    Walton MI; Workman P
    J Chromatogr; 1988 Sep; 430(2):429-37. PubMed ID: 3235518
    [No Abstract]   [Full Text] [Related]  

  • 43. Embryotoxic and teratogenic action of proguanil, chlorproguanil, and cycloguanil on albino rats.
    Chebotar' NA
    Bull Exp Biol Med; 1974 Dec; 77(6):646. PubMed ID: 4441706
    [No Abstract]   [Full Text] [Related]  

  • 44. The role of S-mephenytoin hydroxylase (CYP2C19) in the metabolism of the antimalarial biguanides.
    Wright JD; Helsby NA; Ward SA
    Br J Clin Pharmacol; 1995 Apr; 39(4):441-4. PubMed ID: 7640152
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conversion of biguanides into substituted s-triazines assayable by GC or mass fragmentography.
    Alkalay D; Volk J; Bartlett MF
    J Pharm Sci; 1976 Apr; 65(4):525-9. PubMed ID: 1271251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioequivalence evaluation of a fixed combination of chloroquine and proguanil in a capsule formulation versus a standard medication.
    Chaulet JF; Nony P; Bévalot F; Girard P; Chabaud S; Mounier C; Clair P; Boissel JP; Grelaud G
    Arzneimittelforschung; 2002; 52(5):407-12. PubMed ID: 12087928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liquid chromatographic analysis of cyclotrimethylenetrinitramine in biological fluids using solid-phase extraction.
    Turley CP; Brewster MA
    J Chromatogr; 1987 Oct; 421(2):430-3. PubMed ID: 3429599
    [No Abstract]   [Full Text] [Related]  

  • 48. Japanese poor metabolizers of proguanil do not have an increased risk of malaria chemoprophylaxis breakthrough.
    Mberu EK; Wansor T; Sato H; Nishikawa Y; Watkins WM
    Trans R Soc Trop Med Hyg; 1995; 89(6):658-9. PubMed ID: 8594689
    [No Abstract]   [Full Text] [Related]  

  • 49. Hydrogenolysis as a method for determining chlorguanide.
    SHULTZ RC
    J Am Pharm Assoc Am Pharm Assoc; 1949 Feb; 38(2):84. PubMed ID: 18111461
    [No Abstract]   [Full Text] [Related]  

  • 50. Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil.
    Kaneko A; Bergqvist Y; Takechi M; Kalkoa M; Kaneko O; Kobayakawa T; Ishizaki T; Björkman A
    J Infect Dis; 1999 Apr; 179(4):974-9. PubMed ID: 10068594
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Formation of the diuretic chlorazanil from the antimalarial drug proguanil--implications for sports drug testing.
    Thevis M; Geyer H; Thomas A; Tretzel L; Bailloux I; Buisson C; Lasne F; Schaefer MS; Kienbaum P; Mueller-Stoever I; Schänzer W
    J Pharm Biomed Anal; 2015 Nov; 115():208-13. PubMed ID: 26226108
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans.
    Funck-Brentano C; Bosco O; Jacqz-Aigrain E; Keundjian A; Jaillon P
    Clin Pharmacol Ther; 1992 May; 51(5):507-12. PubMed ID: 1587064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Synthesis and spectral properties of substituted guanamines suitable for chromatography of biguanides].
    Bellenger P; Hamon M; Mahuzier G
    Ann Pharm Fr; 1983; 41(4):327-37. PubMed ID: 6670817
    [No Abstract]   [Full Text] [Related]  

  • 54. Analytical method for the quantitative determination of cyanuric acid as the degradation product of sodium dichloroisocyanurate in urine by liquid chromatography mass spectrometry.
    Patel K; Jones K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 853(1-2):360-3. PubMed ID: 17409034
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pharmacokinetics of blood glucose lowering biguanide derivatives].
    Mehnert H
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():137-42. PubMed ID: 4906018
    [No Abstract]   [Full Text] [Related]  

  • 56. Development and validation of a UPLC-MS/MS method for simultaneous determination of fotagliptin and its two major metabolites in human plasma and urine.
    Wang Z; Jiang J; Hu P; Zhao Q
    Bioanalysis; 2017 Feb; 9(4):381-393. PubMed ID: 28102710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms.
    Coller JK; Somogyi AA; Bochner F
    Br J Clin Pharmacol; 1999 Aug; 48(2):158-67. PubMed ID: 10417492
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Distribution of n-butylbiguanide-14C hydrochloride in mouse tissues.
    Yoh YJ
    Jpn J Pharmacol; 1967 Sep; 17(3):439-49. PubMed ID: 5300191
    [No Abstract]   [Full Text] [Related]  

  • 59. Chlorproguanil and chlorcycloguanil concentrations in human plasma and urine after Lapudrine administration.
    Edstein MD; Veenendaal JR
    Trans R Soc Trop Med Hyg; 1987; 81(1):136-9. PubMed ID: 3445299
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro.
    Thapar MM; Gupta S; Spindler C; Wernsdorfer WH; Björkman A
    Trans R Soc Trop Med Hyg; 2003; 97(3):331-7. PubMed ID: 15228254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.